Changes in PSA-Based Early Detection of Prostate Cancer over a 12-Year Period: Findings from the German KABOT Study
Kay-Patrick Braun, Torsten Vogel, Matthias May, Christian Gilfrich, Markus Herrmann, Anton P. Kravchuk, Julia Maurer, Ingmar Wolff

TL;DR
A 12-year study in Germany found no significant change in awareness or use of PSA testing for prostate cancer, but highlights the need for targeted counseling based on education levels.
Contribution
The study provides longitudinal evidence on PSA-based early detection in a non-organized European setting, identifying subgroups needing targeted counseling.
Findings
Higher educational attainment was independently associated with greater awareness and utilization of PSA testing.
Study phase was not independently associated with awareness or utilization in primary analyses.
Post-stratified analyses suggested study phase effects may reflect population composition differences.
Abstract
Background: The effectiveness of prostate-specific antigen (PSA)-based early detection of prostate cancer remains controversial and implementation-dependent. Screening policy changes have substantially altered PSA testing behavior in the United States, yet longitudinal evidence from non-organized European settings is limited. We assessed 12-year changes in awareness and utilization of PSA-based early detection and identified subgroups requiring targeted counseling. Methods: Two cross-sectional survey waves were conducted in 2009 (Study Phase 1) and 2021 (Study Phase 2) among men recruited via general practitioner practices in urban and rural regions of Germany. The survey was developed and reported according to the Consensus-Based Checklist for Reporting of Survey Studies (CROSS). Identical questionnaires were used across phases. Endpoints were awareness of PSA-based early detection and…
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Click any figure to enlarge with its caption.
Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6
Figure 7Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsProstate Cancer Diagnosis and Treatment · Cardiovascular Health and Risk Factors · Health Promotion and Cardiovascular Prevention
